Veniti
The Vici Venous Stent® System - Boston Scientific.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor | €0.0 | round |
| investor investor investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
$160m Valuation: $160m | Acquisition | ||
| Total Funding | 000k | ||
Tekla Capital Management(exited)
Baird Capital(exited)
Cultivation Capital(exited)
Prolog Ventures(exited)
InterWest Partners(exited)
Charter Life Sciences(exited)
Mark Klopp(exited)
Wil Samson(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
